Segment Information and Concentrations of Risk (Tables)

12 Months Ended

Dec. 31, 2013

Segment Information and Concentrations of Risk Disclosure [Abstract]

Segment Financial Information

The following tables present operating group financial information for the periods indicated.

	Year ended December 31, 2013
	Healthcare		DNA		Total
Net sales:
Software and other	$	57,371	$	21,204	$	78,575
Professional Services		28,290		15,540		43,830
Maintenance and EDI		107,220		2,042		109,262
Total net sales		192,881		38,786		231,667
Expenses		171,838		35,094		206,932
Segment income	$	21,043	$	3,692		24,735
Net corporate/other expenses (1)						60,829
Loss before income taxes					$	(36,094	)

	Year ended December 31, 2012
	Healthcare		DNA			Total
Net sales:
Software and other	$	78,941	$	15,525		$	94,466
Professional Services		27,552		13,426			40,978
Maintenance and EDI		110,894		2,566			113,460
Total net sales		217,387		31,517			248,904
Expenses		192,408		33,315			225,723
Segment income (loss)	$	24,979	$	(1,798	)		23,181
Net corporate/other expenses (1)							47,910
Loss before income taxes						$	(24,729	)

	Year ended December 31, 2011
	Healthcare		DNA		Total
Net sales:
Software and other	$	76,947	$	4,001	$	80,948
Professional Services		23,437		18,468		41,905
Maintenance and EDI		109,562		13		109,575
Total net sales		209,946		22,482		232,428
Expenses		166,898		20,406		187,304
Segment income	$	43,048	$	2,076		45,124
Net corporate/other expenses (1)						46,990
Loss before income taxes					$	(1,866	)

(1) Net corporate/other expenses include public company costs, corporate administration expenses, amortization expense

	Healthcare		DNA		Corporate/ Other			Consolidated
Depreciation and amortization
Year ended December 31, 2013	$	13,522	$	3,949	$	49		$	17,520
Restructuring and Other One Time Charges
Year ended December 31, 2013	$	2,886	$	405	$	565		$	3,856
Assets as of December 31, 2013	$	333,789	$	42,894	$	5,728		$	382,411
	Healthcare		DNA		Corporate/ Other			Consolidated
Depreciation and amortization
Year ended December 31, 2012	$	16,049	$	4,187	$	59		$	20,295
Restructuring and Other One Time Charges
Year ended December 31, 2012	$	333	$	497	$	-		$	830
Assets as of December 31, 2012	$	412,841	$	33,207	$	(9,195	)	$	436,853
	Healthcare		DNA		Corporate/ Other			Consolidated
Depreciation and amortization
Year ended December 31, 2011	$	19,311	$	2,165	$	732		$	22,208
Restructuring and Other One Time Charges
Year ended December 31, 2011	$	1,216	$	-	$	-		$	1,216
Assets as of December 31, 2011	$	354,442	$	47,722	$	48,223		$	450,387

Segment Financial Information by Customer Location

The following tables present certain geographic information, based on location of customer:

	Net Sales for the Years Ended December 31,
	2013		2012		2011
United States of America	$	216,560	$	232,848	$	211,907
Europe		7,566		8,687		8,767
Japan		2,061		2,190		5,312
Korea		1,105		1,018		1,449
Canada		1,718		1,707		1,598
Other		2,657		2,454		3,395
Total Net Sales	$	231,667	$	248,904	$	232,428

	Long Lived Assets
	2013		2012		2011
United States of America	$	4,184	$	4,316	$	3,866
Canada		487		569		520
Europe		68		79		3
Other		-		-		2
Total	$	4,739	$	4,964	$	4,391